EMERGING BIOMARKERS AT THE CROSSROADS OF CARDIAC, RENAL, AND HEPATIC DYSFUNCTION: A NEW ERA IN MULTIORGAN RISK STRATIFICATION
Academic Medical Journal · 24.03.2026 · 6 (1) · 1-13
DOI: 10.53582/6fx2nm97 ↗Kurz gefasst
Fachartikel in der Zeitschrift Academic Medical Journal, online erschienen am 24.03.2026. Verfasst von Marija Vavlukis und 10 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
The cardio-hepato-renal axis represents a complex interplay of organ systems whose dysfunction contributes to high morbidity and mortality in chronic disease. Traditional biomarkers such as natriuretic peptides, creatinine, and liver transaminases provide limited insight into the early and overlapping pathophysiological changes within this tri-organ network. Emerging biomarkers - including ischemia-modified albumin (IMA), soluble ST2 (sST2), galectin-3, thrombin–antithrombin complex (TAT), neutrophil gelatinase-associated lipocalin (NGAL), hyaluronic acid (HA), and matrix metalloproteinase-9 (MMP-9) - offer novel perspectives by reflecting oxidative stress, myocardial fibrosis, neurohumoral activation, coagulation activity, renal tubular injury, extracellular matrix remodeling, and systemic inflammation. This review synthesizes current evidence on the mechanistic relevance, diagnostic performance, and prognostic value of these biomarkers across diverse clinical contexts such as acute coronary syndromes, heart failure, atrial fibrillation, sepsis, and cardio-hepato-renal syndrome. We highlight their potential integration into multimarker panels and precision medicine strategies, emphasizing their role in early detection, risk stratification, and therapeutic monitoring. By shifting from isolated organ assessment to systemic biomarker profiling, these tools may transform clinical practice, enabling more holistic management of multiorgan dysfunction and improving patient outcomes.
Zitieren
APA
Vavlukis, M., Petkovski, D., Todorovski, S., Vranjko, E., Dobjani, A., Dimitrovski, M. K., Canoska, N. T., Mitreski, S., Donevska, G., Poposka, L., & Zivadinovik, J. (2026). EMERGING BIOMARKERS AT THE CROSSROADS OF CARDIAC, RENAL, AND HEPATIC DYSFUNCTION: A NEW ERA IN MULTIORGAN RISK STRATIFICATION. Academic Medical Journal, 6(1), 1-13. https://doi.org/10.53582/6fx2nm97
Vancouver
Vavlukis M, Petkovski D, Todorovski S, Vranjko E, Dobjani A, Dimitrovski MK, et al. EMERGING BIOMARKERS AT THE CROSSROADS OF CARDIAC, RENAL, AND HEPATIC DYSFUNCTION: A NEW ERA IN MULTIORGAN RISK STRATIFICATION. Academic Medical Journal. 2026;6(1):1-13. doi:10.53582/6fx2nm97
BibTeX
@article{Vavlukis2026,
author = {Vavlukis, Marija and Petkovski, Dusan and Todorovski, Slavce and Vranjko, Elif and Dobjani, Amela and Dimitrovski, Melina Kuzmanovska and Canoska, Natasa Taneska and Mitreski, Stojan and Donevska, Gordana and Poposka, Lidija and Zivadinovik, Julija},
title = {EMERGING BIOMARKERS AT THE CROSSROADS OF CARDIAC, RENAL, AND HEPATIC DYSFUNCTION: A NEW ERA IN MULTIORGAN RISK STRATIFICATION},
journal = {Academic Medical Journal},
year = {2026},
volume = {6},
number = {1},
pages = {1--13},
doi = {10.53582/6fx2nm97}
}
EUVIMED